Skip to main content
CIN- L67120MH1995PLC084899


Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Auro Laboratories Ltd.

NSE : BSE : 530233 ISIN CODE : INE292C01011Industry : Pharmaceuticals

News

  • Auro Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026 20 Jul 2026 | 19:50 | Dion Global

    As of June 2026 52.40% is owned by Indian Promoters and 47.60% by Public. Top five Promoters holding highest number of shares of Auro Laboratories co...more...

  • Auro Laboratories - Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015 16 Jul 2026 | 18:45 | Dion Global

    The Letter being send to the shareholders containing the web-link of the Annual Report of the Company for the FY 2025-2026 is enclosed.more...

  • Auro Laboratories - Reg. 34 (1) Annual Report. 16 Jul 2026 | 18:34 | Dion Global

    Enclosed Annual report of the Company for the FY 2025-2026more...

  • Auro Laboratories - Notice Of 37Th Annual General Meeting (AGM) Scheduled On Tuesday, August 11, 2026 16 Jul 2026 | 18:23 | Dion Global

    Enclosed Notice of 37th Annual General Meeting of the Company scheduled on August 11 2026 at 11:30a.m. (IST)more...

  • Auro Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Jul 2026 | 18:17 | Dion Global

    Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026.more...

  • Auro Laboratories - Announcement under Regulation 30 (LODR)-Change in Management 30 Jun 2026 | 19:09 | Dion Global

    Auro Laboratories Limited hereby approve the re-appointment of Mr. Kiran Suresh Kulkarni as a Whole Time Director.more...

  • Auro Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Dated June 30, 2026 30 Jun 2026 | 18:53 | Dion Global

    Auro Laboratories Limited scheduled the Board Meeting on June 30 2026 to transact the business matter which are attached herewith.more...

  • Auro Laboratories Q4 net profit zooms 148.72% at Rs 0.97 cr 30 May 2026 | 18:01 | Dion Global

    The company reported standalone net profit of Rs 0.97 crore for the quarter ended March 31 2026 as compared to Rs 0.39 crore in the same per...more...

  • Auro Laboratories - Announcement under Regulation 30 (LODR)-Change in Management 29 May 2026 | 20:54 | Dion Global

    Enclosed herewith appointment of Chief Financial Officer Tax Auditor Internal Auditor and Reappointment of Cost Auditor.more...

  • Auro Laboratories - Results For The Year Ended March 31, 2026 29 May 2026 | 20:40 | Dion Global

    Enclosed herewith Financial Results for the year ended March 31 2026more...

  • Auro Laboratories - Board Meeting Outcome for Held On May 29, 2026 29 May 2026 | 20:28 | Dion Global

    Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that...more...

  • Auro Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) 28 May 2026 | 20:01 | Dion Global

    Auro Laboratories Limited has submitted the Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 for Resignation of Mr. Kuntal Pan...more...

  • Auro Laboratories - Board Meeting Intimation for Board Meeting To Be Held On May 29, 2026 25 May 2026 | 20:39 | Dion Global

    Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and...more...

  • Auro Laboratories - Receipt Of 'Certification Of Substances Department' From European Directorate For The Quality Of Medicine 05 May 2026 | 19:16 | Dion Global

    Auro Laboratories Limited submits that the Company has received a \Certification of Substances Department\ from the European Directorate for...more...

  • Auro Laboratories - Receipt Of 'Certificate Of GMP Compliance Of A Manufacturer' From Swissmedic Swiss Agency For Therapeutic 05 May 2026 | 19:10 | Dion Global

    Auro Laboratories Limited submits that the Company has received a Certificate of GMP Compliance of a Manufacturer from Swissmedic Swiss Agency for Th...more...

  • Auro Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 20 Apr 2026 | 19:00 | Dion Global

    As of March 2026 52.17% is owned by Indian Promoters and 47.82% by Public. Top five Promoters holding highest number of shares of Auro Labor...more...

  • Auro Laboratories - Announcement under Regulation 30 (LODR)-Credit Rating 14 Apr 2026 | 18:16 | Dion Global

    Auro Laboratories Limited has submitted the Disclosure in relation to Credit Rating obtained by the Company from Acuite Ratings & Research Limited.more...

  • Auro Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Apr 2026 | 18:00 | Dion Global

    Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex78499.17-0.58%
NSE Index24570.65-0.26%
B500DIVL503610.360.20%
BSE 1000 11106.65-0.19%
BSE 100LCTMC9269.55-0.36%
BSE Auto 65073.811.33%

Commodity

Gold1491970.82%
Silver2321872.89%
Copper1396.3242.40%
Crude Oil735814.74%
Lead209.455.80%
Mentha Oil1331.324.72%
Nickel1651.8115.39%

Currency

USD/INR 95.12(-0.23 %)
GBP/INR 127.99(-0.02 %)
EUR/INR 109.72(0.00 %)
JPY/INR 0.60(-0.77 %)
CAD/INR 67.82(0.04 %)
HKD/INR 12.15(-0.06 %)


Announcement Calendar

Upcoming

BOARD MEETINGS
Company Name : 3M India
Date : 14-08-2026